Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T
- Author(s): Small, Eric
- Small, EJ
- Higano, CS
- Kantoff, PW
- Whitmore, JB
- Frohlich, MW
- Petrylak, DP
- et al.
Published Web Locationhttp://europepmc.org/articles/PMC4160816?pdf=render
Background:Sipuleucel-T has demonstrated improved overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC). This analysis examined the effect of sipuleucel-T on time to disease-related pain (TDRP) and time to first use of o
Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.